Danaher completed the acquisition of Genedata.

Danaher, a global life sciences and diagnostics innovator, completed the acquisition of Genedata, a provider of software solutions for biopharmaceutical R&D. Financial terms were not disclosed. “Throughout our trusted relationship with Genedata, we have long admired their innovative software systems anchored in deep scientific expertise. We share a commitment to supporting biopharma companies to accelerate the development of much-needed therapies by providing innovative solutions that help researchers access high-quality insights. We are excited to welcome their team to Danaher and intend to continue expanding Genedata’s capabilities to address new technologies and requirements in this quickly evolving field,” Greg Milosevich, Danaher Vice President.